Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) closed at $21.19 up 2.76% from its previous closing price of $20.62. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.54 million shares were traded. AMPH stock price reached its highest trading level at $21.215 during the session, while it also had its lowest trading level at $20.64.
Ratios:
For a deeper understanding of Amphastar Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.65. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.86.
On February 04, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $66 to $36.
On November 22, 2024, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $55.Wells Fargo initiated its Equal Weight rating on November 22, 2024, with a $55 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 02 ’25 when Petersen Floyd F. sold 500 shares for $23.47 per share. The transaction valued at 11,734 led to the insider holds 77,531 shares of the business.
Petersen Floyd F. bought 500 shares of AMPH for $11,715 on Jul 02 ’25. On Jun 02 ’25, another insider, Petersen Floyd F., who serves as the Director of the company, sold 500 shares for $25.67 each. As a result, the insider received 12,835 and left with 72,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 998877568 and an Enterprise Value of 1497963392. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.69, and their Forward P/E ratio for the next fiscal year is 6.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 2.05 whereas that against EBITDA is 6.033.
Stock Price History:
The Beta on a monthly basis for AMPH is 0.76, which has changed by -0.4929924 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, AMPH has reached a high of $53.96, while it has fallen to a 52-week low of $20.43. The 50-Day Moving Average of the stock is -12.30%, while the 200-Day Moving Average is calculated to be -36.66%.
Shares Statistics:
For the past three months, AMPH has traded an average of 510.55K shares per day and 525620 over the past ten days. A total of 47.67M shares are outstanding, with a floating share count of 34.58M. Insiders hold about 26.64% of the company’s shares, while institutions hold 72.82% stake in the company. Shares short for AMPH as of 1749772800 were 4080346 with a Short Ratio of 7.96, compared to 1747267200 on 4005726. Therefore, it implies a Short% of Shares Outstanding of 4080346 and a Short% of Float of 17.150000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
